This letter is to inform you of this adverse event as the suspect devices (st.Jude - brk 1 needle/ 8.5 sheath sl1 18) are not manufactured or imported by biosense webster, inc.It was reported by the caller that during the transseptal puncture for an afib procedure the patient developed a pericardial effusion.A pericardiocentesis was performed in which 300cc's was removed from the pericardial space.The patient was stabilized and transferred to the ccu for observation.(b)(4).This report reflects information received by fda in the form of a notification per 803.22 (b)(2).
|